Sreeja K. Bhasy, Evelyn Angel, Roselin Samuel, Anisha Shaheen, Veer Dinesh, Ashwathy Senan and Monica Tefilah
Page: 405-408 | Received 20 Feb 2024, Published online: 16 Mar 2024
Full Text Reference XML File PDF File
Hematological parameters have been increasingly recognized as potential biomarkers in the diagnosis and prognosis of breast lesions. This study aims to compare the hematological parameters in patients with benign and malignant breast lesions to identify significant differences that may aid in clinical decision‐making. A retrospective cohort study was conducted using medical records of patients diagnosed with benign and malignant breast lesions at a tertiary care hospital. Data were collected on demographics, clinical characteristics and hematological parameters, including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV) and hemoglobin levels. Comparative analyses were performed to identify significant differences between the two groups. The study included a sample size of 100 patients, with 50 diagnosed with benign lesions and 50 with malignant lesions. Significant differences were found in NLR, PLR and MPV between the two groups. These hematological parameters could serve as adjunctive tools in differentiating between benign and malignant breast lesions. The study highlights the potential utility of hematological parameters in the clinical evaluation of breast lesions. Further research is needed to validate these findings and explore their prognostic value in breast cancer management.
Sreeja K. Bhasy, Evelyn Angel, Roselin Samuel, Anisha Shaheen, Veer Dinesh, Ashwathy Senan and Monica Tefilah. Comparative Study of Hematological Parameters in Benign and Malignant Lesions of the Breast.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.2.405.408
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.2.405.408